Drug Development: Molecular Targets for GI Diseases - Rilegato

Rilegato

ISBN 10: 0896035891 ISBN 13: 9780896035898

Casa editrice: Springer-Verlag GmbH, 1999

Riassunto

The application of molecular techniques to gastroenterology continues to yield important advances in the development of drugs to treat gastrointestinal disorders. Important new drugs have emerged through the collaborative and complementary efforts of basic scientists, clinicians, and clinical researchers in academia and the pharmaceutical industry. The challenge has been exciting, with a few surprises along the way. Consider peptic ulcer disease as an example. The discovery of H receptors and the availability of potent and 2 selective H-receptor antagonists signaled the beginning of a new era 2 in the treatment of gastric hypersecretory states and peptic ulcers. Introduction of proton pump inhibitors offered another therapeutic option. Though H-receptor antagonists and proton pump inhibitors 2 are important and useful drugs, the discovery of the link between H. pylori infection and peptic ulcer disease has led to even more effective pharmacotherapeutic regimens. Our intent in Drug Development: Molecular Targets for GI Diseases is to bring together hands-on experts to review promising areas of gastrointestinal pharmacology. The contemporary topics covered, from a mechanistic viewpoint, are relevant to gastrointestinal inflammation and motility disorders. Authoritative opinions are offered on both future research directions and potential applications for new therapies.

Su questo libro

Dalla quarta di copertina

Drug Development: Molecular Targets for Gastrointestinal Disease brings together a panel of distinguished experts to critically review the many promising new areas of gastrointestinal pharmacology at the molecular level. Key chapters discuss such major themes as the cyclooxygenase-2 inhibitors, the complexities of nitric oxide pathways in the gut, and the influence of cytokines on inflammatory bowel disease, as well as new opportunities for pharmacotherapy, including peptide growth factors, tachykinins-particularly substance P and neurokinins-cholecystokinin receptors, and serotonin. Also examined as possible sites for treating motility disorders and visceral pain are the opioid receptors residing in the gut, and the H3-receptor agonists for treating gut inflammation and pain. Drug Development: Molecular Targets for Gastrointestinal Disease provides a comprehensive review of today's molecular pharmacological approaches to the discovery and development of novel drugs for gastrointestinal and liver diseases. Its extensive references, richly experienced contributors, and cutting-edge syntheses of past, present, and emergent research establish the book as an essential resource for all pharmacologists, medicinal chemists, and clinicians seeking more powerful drugs for the prevention and treatment of gastrointestinal disorders.

Dettagli dell'edizione

• Editore: Springer-Verlag GmbH
• Data di pubblicazione: 1999
• Lingua: Inglese
• ISBN 10: 0896035891
• ISBN 13: 9780896035898
• Rilegatura: Copertina rigida
• Numero di pagine: 292
• Redattore: Guglietta Antonio, Gaginella Timothy S.
• Contatto del produttore: non disponibile
• Persona responsabile: Palgrave Macmillan; ProductSafety@springernature.com; ; Crinan Street 4; London; N1 9XW; Regno Unito